Body mass index (BMI) is a predictor for response to neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.

Yazar
Valero, V
Arun, B
Kau, SW
Buzdar, A
Hortobagyi, GN
Eralp, Y
Smith, TL
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/100527
Koleksiyonlar